Back
ESC Premium Access

Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy

Session: Advances in the Diagnosis and Treatment of Cardiac Amyloidosis
Topic: Infiltrative Myocardial Disease
Speaker: Professor C. Rapezzi (Ferrara, IT)
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)
29 presentations
3 followers

6 more presentations in this session

Prognostic impact of suspected cardiac amyloidosis in aortic stenosis patients referred for transcatheter aortic valve implantation

Speaker: Doctor V. Ferreira (Lisbon, PT)

Access
Abstract
Slides
Like
Thumbnail

Hereditary transthyretin amyloidosis: predictors of conduction disease

Speaker: Doctor A. Dias De Frias (Porto, PT)

Access
Abstract
Slides
Like
Thumbnail

High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

Speaker: Doctor V. Castiglione (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Regional cardiac uptake of 99-Tc-DPD is a novel powerful and independent prognostic marker in cardiac ATTR wild type amyloidosis.

Speaker: Doctor P. Milani (Pavia, IT)

Access
Abstract
Slides
Like
Thumbnail

Quantitative and functional evaluation of endothelial progenitor cells in patients with cardiac amyloidosis

Speaker: Doctor O. Itzhaki Ben Zadok (Petah Tikva, IL)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Advances in the Diagnosis and Treatment of Cardiac Amyloidosis

Speakers: Professor C. Rapezzi, Doctor V. Ferreira, Doctor A. Dias De Frias, Doctor V. Castiglione, Doctor P. Milani...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources